MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,125,591 | -31.6% | 70,174 | -1.1% | 0.00% | -20.0% |
Q2 2023 | $1,645,154 | -7.0% | 70,973 | -6.8% | 0.01% | 0.0% |
Q1 2023 | $1,768,593 | +55.4% | 76,134 | -3.0% | 0.01% | +25.0% |
Q4 2022 | $1,138,353 | -26.5% | 78,453 | -3.4% | 0.00% | -20.0% |
Q3 2022 | $1,549,000 | -1.4% | 81,175 | -6.1% | 0.01% | +25.0% |
Q2 2022 | $1,571,000 | -41.3% | 86,474 | -18.6% | 0.00% | -33.3% |
Q1 2022 | $2,676,000 | -10.0% | 106,200 | -1.4% | 0.01% | 0.0% |
Q4 2021 | $2,973,000 | -12.8% | 107,700 | +2.0% | 0.01% | -14.3% |
Q3 2021 | $3,410,000 | +16.4% | 105,600 | +10.2% | 0.01% | +16.7% |
Q2 2021 | $2,930,000 | +0.4% | 95,800 | 0.0% | 0.01% | 0.0% |
Q1 2021 | $2,917,000 | +50.5% | 95,800 | -2.2% | 0.01% | +50.0% |
Q4 2020 | $1,938,000 | +34.9% | 98,000 | -11.1% | 0.00% | 0.0% |
Q3 2020 | $1,437,000 | +15.0% | 110,200 | 0.0% | 0.00% | +33.3% |
Q2 2020 | $1,250,000 | -20.4% | 110,200 | +0.5% | 0.00% | -40.0% |
Q1 2020 | $1,570,000 | -45.1% | 109,700 | +4.5% | 0.01% | -28.6% |
Q4 2019 | $2,859,000 | -4.9% | 105,000 | 0.0% | 0.01% | -12.5% |
Q3 2019 | $3,006,000 | +10.1% | 105,000 | +6.8% | 0.01% | 0.0% |
Q2 2019 | $2,731,000 | -14.4% | 98,300 | +2.3% | 0.01% | -11.1% |
Q1 2019 | $3,191,000 | +60.8% | 96,100 | +40.7% | 0.01% | +50.0% |
Q4 2018 | $1,985,000 | -35.4% | 68,300 | +2.2% | 0.01% | -25.0% |
Q3 2018 | $3,073,000 | +23.1% | 66,800 | 0.0% | 0.01% | +14.3% |
Q2 2018 | $2,496,000 | +32.4% | 66,800 | +4.7% | 0.01% | +40.0% |
Q1 2018 | $1,885,000 | -14.0% | 63,800 | 0.0% | 0.01% | -16.7% |
Q4 2017 | $2,191,000 | +31.7% | 63,800 | +38.7% | 0.01% | +20.0% |
Q3 2017 | $1,664,000 | +39.9% | 46,000 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $1,189,000 | -40.9% | 46,000 | -19.0% | 0.00% | -42.9% |
Q1 2015 | $2,011,000 | +1.2% | 56,811 | -2.7% | 0.01% | 0.0% |
Q4 2014 | $1,988,000 | -6.4% | 58,371 | +6.1% | 0.01% | -12.5% |
Q3 2014 | $2,123,000 | -0.2% | 55,041 | +0.7% | 0.01% | 0.0% |
Q2 2014 | $2,127,000 | +16.5% | 54,641 | +2.3% | 0.01% | +14.3% |
Q1 2014 | $1,826,000 | +63.3% | 53,421 | +0.2% | 0.01% | +75.0% |
Q4 2013 | $1,118,000 | – | 53,301 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
Grace Capital | 220,769 | $7,815,000 | 1.76% |
AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |